ID   PA2G3_HUMAN             Reviewed;         509 AA.
AC   Q9NZ20; O95768;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 2.
DT   10-MAY-2017, entry version 145.
DE   RecName: Full=Group 3 secretory phospholipase A2;
DE            EC=3.1.1.4;
DE   AltName: Full=Group III secretory phospholipase A2;
DE            Short=GIII sPLA2;
DE            Short=sPLA2-III;
DE   AltName: Full=Phosphatidylcholine 2-acylhydrolase 3;
DE   Flags: Precursor;
GN   Name=PLA2G3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND VARIANT ALA-70.
RX   PubMed=10713052; DOI=10.1074/jbc.275.11.7492;
RA   Valentin E., Ghomashchi F., Gelb M.H., Lazdunski M., Lambeau G.;
RT   "Novel human secreted phospholipase A2 with homology to the group III
RT   bee venom enzyme.";
RL   J. Biol. Chem. 275:7492-7496(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-70.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF HIS-184.
RX   PubMed=12522102; DOI=10.1074/jbc.M211325200;
RA   Murakami M., Masuda S., Shimbara S., Bezzine S., Lazdunski M.,
RA   Lambeau G., Gelb M.H., Matsukura S., Kokubu F., Adachi M., Kudo I.;
RT   "Cellular arachidonate-releasing function of novel classes of
RT   secretory phospholipase A2s (groups III and XII).";
RL   J. Biol. Chem. 278:10657-10667(2003).
RN   [5]
RP   TISSUE SPECIFICITY, INDUCTION, GLYCOSYLATION AT ASN-167 AND ASN-280,
RP   AND MUTAGENESIS OF ASN-167; HIS-184 AND ASN-280.
RX   PubMed=15863501; DOI=10.1074/jbc.M502088200;
RA   Murakami M., Masuda S., Shimbara S., Ishikawa Y., Ishii T., Kudo I.;
RT   "Cellular distribution, post-translational modification, and
RT   tumorigenic potential of human group III secreted phospholipase
RT   A(2).";
RL   J. Biol. Chem. 280:24987-24998(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20393563; DOI=10.1038/nature08895;
RA   Kim J., Lee J.E., Heynen-Genel S., Suyama E., Ono K., Lee K.,
RA   Ideker T., Aza-Blanc P., Gleeson J.G.;
RT   "Functional genomic screen for modulators of ciliogenesis and cilium
RT   length.";
RL   Nature 464:1048-1051(2010).
CC   -!- FUNCTION: PA2 catalyzes the calcium-dependent hydrolysis of the 2-
CC       acyl groups in 3-sn-phosphoglycerides. Shows an 11-fold preference
CC       for phosphatidylglycerol over phosphatidylcholine (PC).
CC       Preferential cleavage: 1-palmitoyl-2-linoleoyl-
CC       phosphatidylethanolamine (PE) > 1-palmitoyl-2-linoleoyl-PC > 1-
CC       palmitoyl-2-arachidonoyl-PC > 1-palmitoyl-2-arachidonoyl-PE. Plays
CC       a role in ciliogenesis. {ECO:0000269|PubMed:12522102,
CC       ECO:0000269|PubMed:20393563}.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10035}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC       Note=Binds 1 Ca(2+) ion per subunit.;
CC   -!- ENZYME REGULATION: Arachidonic acid release is markedly increased
CC       by glypican, a glycosylphosphatidylinositol-anchored heparan
CC       sulfate proteoglycan.
CC   -!- SUBCELLULAR LOCATION: Secreted. Cell membrane. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome,
CC       centriole.
CC   -!- TISSUE SPECIFICITY: Expressed in kidney, heart, liver, and
CC       skeletal muscle. Also present in placenta and peripheral blood
CC       leukocytes. Not detected in brain, colon, thymus, spleen and small
CC       intestine. In lung, expressed in bronchial epithelial cells and
CC       alveolar macrophages, but scarcely detected in alveolar
CC       epithelium, arterial walls and interstitial fibroblasts (at
CC       protein level). In joints of osteoarthritis and rheumatoid
CC       arthritis, expressed in endothelial cells (at protein level). In
CC       normal heart, detected in some vessels. In myocardial tissues with
CC       acute infarction, expressed in vascular endothelial cells adjacent
CC       to cardiomyocytes and those in lesions with granulation.
CC       Expression in cardiomyocytes is scarce (at protein level). In
CC       uterus, breast and colon cancers, detected in tumor cells and
CC       neighboring microvascular endothelium, but not in normal glandular
CC       tissues (at protein level). {ECO:0000269|PubMed:15863501}.
CC   -!- INDUCTION: By IL1B/interleukin-1 beta and TNF in microvascular
CC       endothelial cells (at protein level).
CC       {ECO:0000269|PubMed:15863501}.
CC   -!- PTM: N-glycosylation does not affect the catalytic activity, but
CC       is required for proper secretion. A nonglycosylated form was
CC       observed in several cell types. {ECO:0000269|PubMed:15863501}.
CC   -!- PTM: In several cell types, the N- and C-termini are cleaved off.
CC   -!- SIMILARITY: Belongs to the phospholipase A2 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD15617.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF220490; AAF44746.1; -; mRNA.
DR   EMBL; AC005005; AAD15617.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC025316; AAH25316.1; -; mRNA.
DR   CCDS; CCDS13889.1; -.
DR   RefSeq; NP_056530.2; NM_015715.4.
DR   UniGene; Hs.149623; -.
DR   ProteinModelPortal; Q9NZ20; -.
DR   SMR; Q9NZ20; -.
DR   BioGrid; 119074; 2.
DR   IntAct; Q9NZ20; 2.
DR   STRING; 9606.ENSP00000215885; -.
DR   ChEMBL; CHEMBL4667; -.
DR   SwissLipids; SLP:000001086; -.
DR   iPTMnet; Q9NZ20; -.
DR   PhosphoSitePlus; Q9NZ20; -.
DR   BioMuta; PLA2G3; -.
DR   DMDM; 317373314; -.
DR   EPD; Q9NZ20; -.
DR   PaxDb; Q9NZ20; -.
DR   PeptideAtlas; Q9NZ20; -.
DR   PRIDE; Q9NZ20; -.
DR   DNASU; 50487; -.
DR   Ensembl; ENST00000215885; ENSP00000215885; ENSG00000100078.
DR   GeneID; 50487; -.
DR   KEGG; hsa:50487; -.
DR   UCSC; uc003aka.4; human.
DR   CTD; 50487; -.
DR   DisGeNET; 50487; -.
DR   GeneCards; PLA2G3; -.
DR   H-InvDB; HIX0016386; -.
DR   HGNC; HGNC:17934; PLA2G3.
DR   HPA; HPA021016; -.
DR   MIM; 611651; gene.
DR   neXtProt; NX_Q9NZ20; -.
DR   OpenTargets; ENSG00000100078; -.
DR   PharmGKB; PA38267; -.
DR   eggNOG; ENOG410IF4P; Eukaryota.
DR   eggNOG; ENOG4111S6V; LUCA.
DR   GeneTree; ENSGT00530000063569; -.
DR   HOGENOM; HOG000147808; -.
DR   HOVERGEN; HBG053481; -.
DR   InParanoid; Q9NZ20; -.
DR   KO; K01047; -.
DR   OMA; LAPPLDC; -.
DR   OrthoDB; EOG091G06KL; -.
DR   PhylomeDB; Q9NZ20; -.
DR   TreeFam; TF324679; -.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482925; Acyl chain remodelling of PG.
DR   GenomeRNAi; 50487; -.
DR   PRO; PR:Q9NZ20; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100078; -.
DR   CleanEx; HS_PLA2G3; -.
DR   Genevisible; Q9NZ20; HS.
DR   GO; GO:0005814; C:centriole; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; TAS:ProtInc.
DR   GO; GO:0042629; C:mast cell granule; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0047498; F:calcium-dependent phospholipase A2 activity; TAS:ProtInc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0001675; P:acrosome assembly; IEA:Ensembl.
DR   GO; GO:0050482; P:arachidonic acid secretion; IEA:InterPro.
DR   GO; GO:0060271; P:cilium assembly; IMP:UniProtKB.
DR   GO; GO:0016042; P:lipid catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0019372; P:lipoxygenase pathway; IEA:Ensembl.
DR   GO; GO:0043303; P:mast cell degranulation; IEA:Ensembl.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036148; P:phosphatidylglycerol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:ProtInc.
DR   GO; GO:0007288; P:sperm axoneme assembly; IEA:Ensembl.
DR   Gene3D; 1.20.90.10; -; 2.
DR   InterPro; IPR016090; PLipase_A2_dom.
DR   InterPro; IPR033113; PLipase_A2_His_AS.
DR   Pfam; PF05826; Phospholip_A2_2; 2.
DR   SUPFAM; SSF48619; SSF48619; 2.
DR   PROSITE; PS00118; PA2_HIS; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Cilium biogenesis/degradation;
KW   Complete proteome; Cytoplasm; Cytoskeleton; Disulfide bond;
KW   Glycoprotein; Hydrolase; Lipid degradation; Lipid metabolism;
KW   Membrane; Metal-binding; Polymorphism; Reference proteome; Secreted;
KW   Signal.
FT   SIGNAL        1     19       {ECO:0000255}.
FT   CHAIN        20    509       Group 3 secretory phospholipase A2.
FT                                /FTId=PRO_0000022992.
FT   REGION      150    291       Phospholipase A2-like.
FT   ACT_SITE    184    184
FT   ACT_SITE    214    214       {ECO:0000255|PROSITE-ProRule:PRU10035}.
FT   METAL       158    158       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       160    160       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       162    162       Calcium; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       185    185       Calcium. {ECO:0000250}.
FT   CARBOHYD    167    167       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15863501}.
FT   CARBOHYD    280    280       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:15863501}.
FT   CARBOHYD    325    325       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    396    396       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    439    439       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    159    181       {ECO:0000250}.
FT   DISULFID    180    220       {ECO:0000250}.
FT   DISULFID    187    213       {ECO:0000250}.
FT   DISULFID    211    244       {ECO:0000250}.
FT   VARIANT      70     70       S -> A (in dbSNP:rs2232176).
FT                                {ECO:0000269|PubMed:10713052,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_024555.
FT   VARIANT     116    116       E -> Q (in dbSNP:rs2074734).
FT                                /FTId=VAR_024556.
FT   VARIANT     157    157       L -> V (in dbSNP:rs2074735).
FT                                /FTId=VAR_020288.
FT   VARIANT     307    307       H -> Y (in dbSNP:rs2232180).
FT                                /FTId=VAR_056581.
FT   VARIANT     322    322       S -> R (in dbSNP:rs2072193).
FT                                /FTId=VAR_024557.
FT   VARIANT     378    378       R -> Q (in dbSNP:rs2232183).
FT                                /FTId=VAR_034366.
FT   MUTAGEN     167    167       N->S: Loss of glycosylation.
FT                                {ECO:0000269|PubMed:15863501}.
FT   MUTAGEN     184    184       H->Q: Loss of PGE2 synthesis.
FT                                {ECO:0000269|PubMed:12522102,
FT                                ECO:0000269|PubMed:15863501}.
FT   MUTAGEN     280    280       N->S: Loss of glycosylation.
FT                                {ECO:0000269|PubMed:15863501}.
SQ   SEQUENCE   509 AA;  57167 MW;  ED03BED129B0BC9F CRC64;
     MGVQAGLFGM LGFLGVALGG SPALRWYRTS CHLTKAVPGN PLGYLSFLAK DAQGLALIHA
     RWDAHRRLQS CSWEDEPELT AAYGALCAHE TAWGSFIHTP GPELQRALAT LQSQWEACRA
     LEESPAGARK KRAAGQSGVP GGGHQREKRG WTMPGTLWCG VGDSAGNSSE LGVFQGPDLC
     CREHDRCPQN ISPLQYNYGI RNYRFHTISH CDCDTRFQQC LQNQHDSISD IVGVAFFNVL
     EIPCFVLEEQ EACVAWYWWG GCRMYGTVPL ARLQPRTFYN ASWSSRATSP TPSSRSPAPP
     KPRQKQHLRK GPPHQKGSKR PSKANTTALQ DPMVSPRLDV APTGLQGPQG GLKPQGARWV
     CRSFRRHLDQ CEHQIGPREI EFQLLNSAQE PLFHCNCTRR LARFLRLHSP PEVTNMLWEL
     LGTTCFKLAP PLDCVEGKNC SRDPRAIRVS ARHLRRLQQR RHQLQDKGTD ERQPWPSEPL
     RGPMSFYNQC LQLTQAARRP DRQQKSWSQ
//
